Charles River Laboratories International, Inc. financial data

Symbol
CRL on NYSE
Industry
Services-Commercial Physical & Biological Research
Location
251 Ballardvale St, Wilmington, Massachusetts
Fiscal year end
December 28
Former names
CHARLES RIVER LABORATORIES HOLDINGS INC (to 1/28/2000)
Latest financial report
10-Q - Q2 2024 - Aug 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 157 % +11%
Quick Ratio 35 % +34.6%
Debt-to-equity 122 % -20.2%
Return On Equity 12.4 % -23.5%
Return On Assets 5.54 % -12.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.6M shares +0.7%
Common Stock, Shares, Outstanding 51.6M shares +0.68%
Entity Public Float 10.7B USD -6.2%
Common Stock, Value, Issued 517K USD +0.78%
Weighted Average Number of Shares Outstanding, Basic 51.6M shares +0.65%
Weighted Average Number of Shares Outstanding, Diluted 51.8M shares +0.74%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 4.08B USD -2.41%
Operating Income (Loss) 562M USD -13.2%
Income Tax Expense (Benefit) 94.5M USD -31.3%
Net Income (Loss) Attributable to Parent 442M USD -8.79%
Earnings Per Share, Basic 8.42 USD/shares -11.3%
Earnings Per Share, Diluted 8.36 USD/shares -11.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 179M USD -10.6%
Accounts Receivable, after Allowance for Credit Loss, Current 762M USD -4.8%
Inventory, Net 349M USD +22.4%
Assets, Current 1.5B USD -0.37%
Deferred Income Tax Assets, Net 36.1M USD -6.31%
Property, Plant and Equipment, Net 1.64B USD +11.9%
Operating Lease, Right-of-Use Asset 386M USD -2.78%
Goodwill 3.08B USD +5.59%
Other Assets, Noncurrent 301M USD +93.7%
Assets 7.95B USD +2.26%
Accounts Payable, Current 133M USD -5.07%
Employee-related Liabilities, Current 177M USD -7.41%
Accrued Liabilities, Current 192M USD -12.9%
Contract with Customer, Liability, Current 247M USD -3.97%
Liabilities, Current 948M USD -5.97%
Long-term Debt and Lease Obligation 2.41B USD -10%
Contract with Customer, Liability, Noncurrent 29.1M USD
Deferred Income Tax Liabilities, Net 165M USD -20.4%
Operating Lease, Liability, Noncurrent 429M USD +6.71%
Other Liabilities, Noncurrent 225M USD +26.7%
Liabilities 4.18B USD -6.65%
Accumulated Other Comprehensive Income (Loss), Net of Tax -270M USD -29.5%
Retained Earnings (Accumulated Deficit) 2.05B USD +25.8%
Stockholders' Equity Attributable to Parent 3.72B USD +14.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.73B USD +14.4%
Liabilities and Equity 7.95B USD +2.26%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 130M USD +18.7%
Net Cash Provided by (Used in) Financing Activities 18.3M USD -27.3%
Net Cash Provided by (Used in) Investing Activities -85.8M USD +49.1%
Common Stock, Shares Authorized 120M shares 0%
Common Stock, Shares, Issued 51.7M shares +0.64%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 54.1M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 181M USD -13.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 38.3M USD +3.94%
Deferred Tax Assets, Valuation Allowance 304M USD +3.22%
Operating Lease, Liability 474M USD +8.68%
Depreciation 47.6M USD +9.68%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 380M USD -28.9%
Lessee, Operating Lease, Liability, to be Paid 597M USD +10.5%
Property, Plant and Equipment, Gross 2.98B USD +13.3%
Operating Lease, Liability, Current 54.9M USD +18%
Lessee, Operating Lease, Liability, to be Paid, Year Two 63.4M USD -0.39%
Lessee, Operating Lease, Liability, to be Paid, Year One 70.6M USD +17.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 122M USD +18.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 58.5M USD +4.51%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 24M USD -6.25%
Lessee, Operating Lease, Liability, to be Paid, Year Four 59.9M USD +15.5%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 133M USD -5.04%
Depreciation, Depletion and Amortization 331M USD +7.8%
Deferred Tax Assets, Net of Valuation Allowance 290M USD +12.2%
Interest Expense 137M USD +63%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%